Treatment of first acute rejection episode: Systematic review of level i evidence

Transplantation Proceedings

Volumn 43, Issue 3, 2011, Pages 841-846

  Uslu, A ^a   Nart, A ^a,b  

^a Department of Pediatrics   (Turkey)

^b TCSB   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; OKT 3; POLYCLONAL ANTIBODY; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; CONFERENCE PAPER; DRUG DOSE COMPARISON; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; PRIORITY JOURNAL; RISK REDUCTION; SURVIVAL; SYSTEMATIC REVIEW; TREATMENT FAILURE;

GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79954517886     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.11.018     Document Type: Conference Paper

References (11)

1. S.M. Flechner, C.S. Modlin, and D.P. Serrano Determinants of chronic renal allograft rejection in cyclosporine-treated recipients Transplantation 62 1996 1235
2. J.M. Cecka The UNOS Scientific Renal Transplant Registry J.M. Cecka, P.I. Terasaki, Clinical Transplants 1998 1998 UCLA Tissue Typing Laboratory Los Angeles, Calif 1
3. L.W. Gaber, T.J. Schroeder, and L.W. Moore The correlation of Banff scoring with reversibility of first and recurrent rejection episodes Transplantation 61 1996 1711
4. J. Theodorakis, H. Schneeberger, and W.D. Illner Aggressive treatment of the first acute rejection episode using first-line anti-lymphocytic reparation reduces further acute rejection episodes after human kidney transplantation Transpl Int 11 1998 86
5. A. Baldi, J. Malaise, and M. Mourad A prospective randomized study comparing poly-ATG to mono-OKT3 clonal antibodies for the first rejection therapy after kidney transplantation: long-term results Transplant Proc 32 2000 429
6. A. Djamali, C. Turc-Baron, and P. Portales Low-dose antithymocyte globulins in renal transplantation Transplantation 69 2000 799
7. J.D.I. Ellenhorn, E.S. Woodle, and I. Ghobreal Activation of human T-cells in vivo following treatment of transplant recipients with OKT3 Transplantation 50 1990 608
8. A.O. Gaber, M.R. First, and R.J. Tesi Results of the double-blind, randomized, multicenter, phase III clinical trial of thymoglobulin versus atgam in the treatment of acute graft rejection episodes after renal transplantation Transplantation 66 1998 29
9. C. Mariat, E. Alamartine, and N. Diab A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients Transpl Int 11 1998 231
10. K. Midtvedt, P. Fauchald, and B. Lien Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection Clin Transplant 17 2003 69
11. D.H. Casadei, C. del, M. Rial, and G. Opelz A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection Transplantation 71 2001 53